What's new

Human medicines European public assessment report (EPAR): Skilarence, dimethyl fumarate, Date of authorisation: 23/06/2017, Revision: 13, Status: Authorised

Human medicines European public assessment report (EPAR): Skilarence, dimethyl fumarate, Date of authorisation: 23/06/2017, Revision: 13, Status: Authorised

Mar 17, 2025 - 17:11
 0
Human medicines European public assessment report (EPAR): Skilarence, dimethyl fumarate, Date of authorisation: 23/06/2017, Revision: 13, Status: Authorised
Human medicines European public assessment report (EPAR): Skilarence, dimethyl fumarate, Date of authorisation: 23/06/2017, Revision: 13, Status: Authorised
Read More

Tags:

Previous Article

Merck plots 163 layoffs as it prepares to shutter Pennsylvania manufacturing site

Next Article

Human medicines European public assessment report (EPAR): Cejemly, sugemalimab, ...

Related Posts

Human medicines European public assessment report (EPAR): Truqap, capivasertib, Date of authorisation: 17/06/2024, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 7, 2025  0

Summary of opinion: Prevymis, 27/02/2025 Positive

Summary of opinion: Prevymis, 27/02/2025 Positive

Feb 28, 2025  0

Opinion/decision on a Paediatric investigation plan (PIP): Uplizna, Inebilizumab, decision type: P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s), therapeutic area: Immune system disorders, PIP number: P/0531/2023

Opinion/decision on a Paediatric investigation plan (PI...

Feb 13, 2025  0